3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
27
Burkitt Lymphoma
16
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
9
Leukemia, Biphenotypic, Acute
5
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasm Metastasis
4
Immunoglobulin Light-chain Amyloidosis
4
Smoldering Multiple Myeloma
3
Down Syndrome
3
Carcinoma, Non-Small-Cell Lung
3
Recurrence
2
Neoplasms
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma
2
Lung Neoplasms
2
Hodgkin Disease
2
Breast Neoplasms
2
Brain Neoplasms
2
Blastic Plasmacytoid Dendritic Cell Neoplasm
2
Plasmacytoma
1
Myelodysplastic Syndromes
1
Meningioma
1
Mastocytosis, Systemic
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Plasma Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Interventions
Cyclophosphamide
9
mogamulizumab
6
Biopsy
6
fludarabine
5
fludarabine phosphate
4
Specimen Handling
4
Immunoglobulin G
4
Disulfides
4
Brentuximab Vedotin
4
ruxolitinib
3
romidepsin
3
pembrolizumab
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Magnetic Resonance Spectroscopy
3
Lenalidomide
3
Etoposide
3
Busulfan
3
hypericin
2
Whole-Body Irradiation
2
Vincristine
2
Tacrolimus
2
Prednisone
2
Nivolumab
2
Melphalan
2
Depsipeptides
2
tofacitinib
1
thymoglobulin
1
tazemetostat
1
talimogene laherparepvec
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Cutaneous
×
dexamethasone 21-phosphate
×
1 year
×
Clear all
No trials found.